Germline gain-of-function mutations in RAF1 cause Noonan syndrome
10.1038/ng2078
Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Razzaque, M. A., Nishizawa, T., Komoike, Y., Yagi, H., Furutani, M., Amo, R., Kamisago, M., Momma, K., Katayama, H., Nakagawa, M., Fujiwara, Y., Matsushima, M., Mizuno, K., Tokuyama, M., Hirota, H., Muneuchi, J., Higashinakagawa, T., & Matsuoka, R. (2007). Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nature Genetics, 39(8), 1013–1017.

Authors 18
  1. M Abdur Razzaque (first)
  2. Tsutomu Nishizawa (additional)
  3. Yuta Komoike (additional)
  4. Hisato Yagi (additional)
  5. Michiko Furutani (additional)
  6. Ryunosuke Amo (additional)
  7. Mitsuhiro Kamisago (additional)
  8. Kazuo Momma (additional)
  9. Hiroshi Katayama (additional)
  10. Masao Nakagawa (additional)
  11. Yuko Fujiwara (additional)
  12. Masaki Matsushima (additional)
  13. Katsumi Mizuno (additional)
  14. Mika Tokuyama (additional)
  15. Hamao Hirota (additional)
  16. Jun Muneuchi (additional)
  17. Toru Higashinakagawa (additional)
  18. Rumiko Matsuoka (additional)
References 29 Referenced 414
  1. Noonan, J.A. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am. J. Dis. Child. 116, 373–380 (1968). (10.1001/archpedi.1968.02100020377005) / Am. J. Dis. Child. by JA Noonan (1968)
  2. Allanson, J.E. Noonan syndrome. J. Med. Genet. 24, 9–13 (1987). (10.1136/jmg.24.1.9) / J. Med. Genet. by JE Allanson (1987)
  3. Tartaglia, M. et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465–468 (2001). (10.1038/ng772) / Nat. Genet. by M Tartaglia (2001)
  4. Tartaglia, M. et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70, 1555–1563 (2002). (10.1086/340847) / Am. J. Hum. Genet. by M Tartaglia (2002)
  5. Fragale, A., Tartaglia, M., Wu, J. & Gelb, B.D. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum. Mutat. 23, 267–277 (2004). (10.1002/humu.20005) / Hum. Mutat. by A Fragale (2004)
  6. Schubbert, S. et al. Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 38, 331–336 (2006). (10.1038/ng1748) / Nat. Genet. by S Schubbert (2006)
  7. Carta, C. et al. Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. Am. J. Hum. Genet. 79, 129–135 (2006). (10.1086/504394) / Am. J. Hum. Genet. by C Carta (2006)
  8. Roberts, A.E. et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat. Genet. 39, 70–74 (2007). (10.1038/ng1926) / Nat. Genet. by AE Roberts (2007)
  9. Tartaglia, M. et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat. Genet. 39, 75–79 (2007). (10.1038/ng1939) / Nat. Genet. by M Tartaglia (2007)
  10. Bentires-Alj, M., Kontaridis, M.I. & Neel, B.G. Stops on the Ras pathway in human genetic disease. Nat. Med. 12, 283–285 (2006). (10.1038/nm0306-283) / Nat. Med. by M Bentires-Alj (2006)
  11. Kratz, C.P. et al. Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle 5, 1607–1611 (2006). (10.4161/cc.5.15.3128) / Cell Cycle by CP Kratz (2006)
  12. Gelb, B.D. & Tartaglia, M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum. Mol. Genet. 15, R220–R226 (2006). (10.1093/hmg/ddl197) / Hum. Mol. Genet. by BD Gelb (2006)
  13. Aoki, Y. et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37, 1038–1040 (2005). (10.1038/ng1641) / Nat. Genet. by Y Aoki (2005)
  14. Niihori, T. et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat. Genet. 38, 294–296 (2006). (10.1038/ng1749) / Nat. Genet. by T Niihori (2006)
  15. Rodriguez-Viciana, P. et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311, 1287–1290 (2006). (10.1126/science.1124642) / Science by P Rodriguez-Viciana (2006)
  16. Tartaglia, M. et al. PTPN11 mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic Heterogeneity. Am. J. Hum. Genet. 70, 1555–1563 (2002). (10.1086/340847) / Am. J. Hum. Genet. by M Tartaglia (2002)
  17. Marshall, C.J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4, 82–89 (1994). (10.1016/0959-437X(94)90095-7) / Curr. Opin. Genet. Dev. by CJ Marshall (1994)
  18. Schubbert, S. et al. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7, 295–308 (2007). (10.1038/nrc2109) / Nat. Rev. Cancer by S Schubbert (2007)
  19. Garnett, M.J. & Marais, R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6, 313–319 (2004). (10.1016/j.ccr.2004.09.022) / Cancer Cell by MJ Garnett (2004)
  20. Heidecker, G. et al. Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol. Cell. Biol. 10, 2503–2512 (1990). (10.1128/MCB.10.6.2503) / Mol. Cell. Biol. by G Heidecker (1990)
  21. Zebisch, A. et al. Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia. Cancer Res. 66, 3401–3408 (2006). (10.1158/0008-5472.CAN-05-0115) / Cancer Res. by A Zebisch (2006)
  22. Emuss, V. et al. Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF. Cancer Res. 65, 9719–9726 (2005). (10.1158/0008-5472.CAN-05-1683) / Cancer Res. by V Emuss (2005)
  23. Chan, E.Y. et al. Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity. Mol. Carcinog. 33, 189–197 (2002). (10.1002/mc.10031) / Mol. Carcinog. by EY Chan (2002)
  24. Dumaz, N. & Marais, R. Protein Kinase A Blocks Raf-1 Activity by Stimulating 14–3-3 Binding and Blocking Raf-1 Interaction with Ras. J. Biol. Chem. 278, 29819–29823 (2003). (10.1074/jbc.C300182200) / J. Biol. Chem. by N Dumaz (2003)
  25. Harris, I.S. et al. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation 110, 718–723 (2004). (10.1161/01.CIR.0000138190.50127.6A) / Circulation by IS Harris (2004)
  26. Yamazaki, T. et al. Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 29, 2491–2501 (1997). (10.1006/jmcc.1997.0488) / J. Mol. Cell. Cardiol. by T Yamazaki (1997)
  27. Bueno, O.F. et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341–6350 (2000). (10.1093/emboj/19.23.6341) / EMBO J. by OF Bueno (2000)
  28. Kimmel, C.B. et al. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253–310 (1995). (10.1002/aja.1002030302) / Dev. Dyn. by CB Kimmel (1995)
  29. Komoike, Y. et al. Zebrafish Polycomb group gene ph2α is required for epiboly and tailbud formation acting downstream of FGF signaling. Biochem. Biophys. Res. Commun. 328, 858–866 (2005). (10.1016/j.bbrc.2005.01.031) / Biochem. Biophys. Res. Commun. by Y Komoike (2005)
Dates
Type When
Created 18 years, 2 months ago (July 1, 2007, 1:20 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:14 p.m.)
Indexed 1 week, 1 day ago (Aug. 27, 2025, 12:08 p.m.)
Issued 18 years, 2 months ago (July 1, 2007)
Published 18 years, 2 months ago (July 1, 2007)
Published Online 18 years, 2 months ago (July 1, 2007)
Published Print 18 years, 1 month ago (Aug. 1, 2007)
Funders 0

None

@article{Razzaque_2007, title={Germline gain-of-function mutations in RAF1 cause Noonan syndrome}, volume={39}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/ng2078}, DOI={10.1038/ng2078}, number={8}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Razzaque, M Abdur and Nishizawa, Tsutomu and Komoike, Yuta and Yagi, Hisato and Furutani, Michiko and Amo, Ryunosuke and Kamisago, Mitsuhiro and Momma, Kazuo and Katayama, Hiroshi and Nakagawa, Masao and Fujiwara, Yuko and Matsushima, Masaki and Mizuno, Katsumi and Tokuyama, Mika and Hirota, Hamao and Muneuchi, Jun and Higashinakagawa, Toru and Matsuoka, Rumiko}, year={2007}, month=jul, pages={1013–1017} }